We are live on ! Find out more
Ingalls & Snyder

Ingalls & Snyder Portfolio holdings

AUM $3.91B Turnover 11.18%
1-Year Est. Return 60.54%
 

Ingalls & Snyder is an investment management firm founded in 1924 by Roscoe C. Ingalls and John T. Snyder. Custom portfolio management is the core of what it offers clients, alongside wealth planning and family office services. It also manages money for institutions such as foundations and corporate retirement plans.

This Fund
S&P 500
This Quarter Est. Return
+11.84%
1 Year Est. Return
+60.54%
3 Year Est. Return
+249.52%
5 Year Est. Return
+323.37%
10 Year Est. Return
+892.94%
AUM
$3.91B
AUM Growth
+$249M
Cap. Flow
-$66M
Cap. Flow %
-1.69%
Top 10 Hldgs %
49.77%
Holding
501
New
25
Increased
103
Reduced
200
Closed
31
Avg Time Held Equity + Options
6.2 years
Top 10 Avg Time Held Equity + Options
5.5 years
Top 20 Avg Time Held Equity + Options
4.4 years
Avg Time Held Equity only
6.4 years
Top 10 Avg Time Held Equity only
5.5 years
Top 20 Avg Time Held Equity only
4.4 years

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$28.7M
2
STRS icon
STRATUS PPTYS INC
STRS
+$25.8M
3
OMER icon
Omeros
OMER
+$8.54M
4
PBI icon
Pitney Bowes
PBI
+$4.54M
5
CRS icon
Carpenter Technology
CRS
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.95%
2 Technology 12.71%
3 Energy 11.38%
4 Materials 10.96%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MDT icon
176
Medtronic
MDT
$132B
$1.71M 0.04%
19,808
-125
-0.6% -$11K
2013 Q2
53 quarters
ED icon
177
Consolidated Edison
ED
$44.9B
$1.68M 0.04%
16,448
-747
-4% -$80.9K
2013 Q2
53 quarters
PLPC icon
178
Preformed Line Products
PLPC
$1.4B
$1.66M 0.04%
4,070
– –
2024 Q3
8 quarters
XLV icon
179
State Street Health Care Select Sector SPDR ETF
XLV
$50.5B
$1.66M 0.04%
9,839
-40
-0.4% -$6.67K
2016 Q2
41 quarters
GMAB icon
180
Genmab
GMAB
$31.7B
$1.66M 0.04%
46,417
-4,424
-9% -$140K
2024 Q1
10 quarters
DFJ icon
181
WisdomTree Japan SmallCap Dividend Fund
DFJ
$435M
$1.65M 0.04%
14,248
-54
-0.4% -$6.02K
2026 Q1
2 quarters
STRA icon
182
Strategic Education
STRA
$1.2B
$1.62M 0.04%
20,881
-43
-0.2% -$3.49K
2014 Q1
50 quarters
KRE icon
183
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.35B
$1.6M 0.04%
23,000
– –
2024 Q1
10 quarters
VUG icon
184
Vanguard Morningstar Growth ETF
VUG
$219B
$1.57M 0.04%
17,422
-660
-4% -$57.8K
2019 Q2
29 quarters
PBA icon
185
Pembina Pipeline
PBA
$29.3B
$1.57M 0.04%
35,186
-215
-0.6% -$10.4K
2013 Q2
53 quarters
SLV icon
186
iShares Silver Trust
SLV
$24.8B
$1.56M 0.04%
28,714
– –
2016 Q2
41 quarters
UHAL.B icon
187
U-Haul Holding Co Series N
UHAL.B
$9.41B
$1.55M 0.04%
29,382
-836
-3% -$50.3K
2022 Q4
15 quarters
AMT icon
188
American Tower
AMT
$88.9B
$1.54M 0.04%
9,422
-26
-0.3% -$4.46K
2013 Q4
51 quarters
VFH icon
189
Vanguard Financials ETF
VFH
$13.8B
$1.54M 0.04%
11,839
+200
+2% +$27.7K
2020 Q1
26 quarters
HUN icon
190
Huntsman Corp
HUN
$1.67B
$1.52M 0.04%
181,564
+176,514
+3,495% +$1.82M
2022 Q1
18 quarters
VRTX icon
191
Vertex Pharmaceuticals
VRTX
$137B
$1.52M 0.04%
2,903
– –
2021 Q4
19 quarters
VICI icon
192
VICI Properties
VICI
$27.5B
$1.51M 0.04%
65,814
-25
-0% -$644
2023 Q4
11 quarters
XLC icon
193
State Street Communication Services Select Sector SPDR ETF
XLC
$22.3B
$1.48M 0.04%
13,343
+250
+2% +$27.8K
2019 Q3
28 quarters
HWM icon
194
Howmet Aerospace
HWM
$87.8B
$1.47M 0.04%
+6,486
New +$1.71M
2026 Q3
0 quarters
HUBB icon
195
Hubbell
HUBB
$23.1B
$1.46M 0.04%
3,223
– –
2016 Q4
39 quarters
TRUP icon
196
Trupanion
TRUP
$1.49B
$1.46M 0.04%
62,500
– –
2020 Q3
24 quarters
KFY icon
197
Korn Ferry
KFY
$4.23B
$1.46M 0.04%
20,320
– –
2013 Q2
53 quarters
CORT icon
198
CALL
Corcept Therapeutics
CORT
$7.88B
$1.44M 0.04%
12,500
– –
2025 Q3
4 quarters
TSLA icon
199
Tesla
TSLA
$1.54T
$1.4M 0.04%
3,942
+165
+4% +$59K
2020 Q1
26 quarters
IGSB icon
200
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.7B
$1.36M 0.03%
26,455
– –
2016 Q2
41 quarters

Similar funds

Ingalls & Snyder's Q3 2026 Portfolio in Review

As of Q3 2026, Ingalls & Snyder held 501 positions worth $3.91B, up 6.8% from $3.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ingalls & Snyder's Q3 2026 filing shows 25 new, 103 increased, 200 reduced and 31 closed positions. Its largest new stake was Howmet Aerospace: 6,486 shares worth $1.47M. The largest sale was Corcept Therapeutics, an estimated $28.7M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Energy.

  • Ingalls & Snyder's largest Q3 2026 buy was Howmet Aerospace: 6,486 shares worth $1.47M.
  • Ingalls & Snyder added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $11.5M increase.
  • Ingalls & Snyder's biggest Q3 2026 reduction was Corcept Therapeutics, cutting an estimated $28.7M.
  • Ingalls & Snyder fully exited STRATUS PPTYS INC in Q3 2026, selling an estimated $25.8M.
  • Ingalls & Snyder's ten largest holdings make up 50% of its $3.91B portfolio in Q3 2026.
  • Ingalls & Snyder opened 25 new positions and closed 31 in Q3 2026.
  • Ingalls & Snyder's portfolio value rose 6.8% quarter-over-quarter to $3.91B.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.